Jan 18 (Reuters) - Adalta Ltd 1AD.AX
* Adalta receives orphan designation for ad-114-1ad.ax
* Received orphan drug designation from united states FDA for a drug candidate used for treatment of Idiopathic Pulmonary Fibrosis Source text for Eikon: ID:nASX5B1hCT Further company coverage: 1AD.AX